Can J Public Health,
Journal Year:
2023,
Volume and Issue:
114(6), P. 947 - 955
Published: July 31, 2023
Abstract
Objectives
Findings
of
previous
studies
examining
the
relationship
between
cannabis
use
and
workplace
injury
have
been
conflicting,
likely
due
to
methodological
shortcomings,
including
cross-sectional
designs
exposure
measures
that
lack
consideration
for
timing
use.
The
objective
was
estimate
association
(before
and/or
at
work)
non-workplace
risk
injury.
Methods
Canadian
workers
participating
in
a
yearly
longitudinal
study
(from
2018
2020)
with
least
two
adjacent
years
survey
data
comprised
analytic
sample
(
n
=
2745).
past-year
(no
use,
use).
outcome
(yes/no).
Absolute
risks
relative
(RR)
95%
confidence
intervals
(CIs)
were
estimated
one
time
point
following
point.
Models
adjusted
personal
work
variables
also
stratified
by
whether
respondents’
jobs
safety-sensitive.
Results
Compared
no
there
difference
(RR
1.09,
95%CI
0.83–1.44).
However,
associated
an
almost
two-fold
increased
experiencing
1.97,
1.32–2.93).
similar
safety-sensitive
non-safety-sensitive
work.
Conclusion
It
is
important
distinguish
when
considering
safety
impacts
implications
policies
substantiate
need
worker
education
on
Addiction,
Journal Year:
2023,
Volume and Issue:
118(11), P. 2062 - 2072
Published: June 28, 2023
Abstract
Aims
We
provide
a
narrative
summary
of
research
on
changes
in
cannabis
arrests,
products
and
prices,
use
cannabis‐related
harm
since
legalization.
Methods
systematically
searched
for
the
impacts
legalization
Canada
PubMed,
Embase,
Statistics
government
websites
Google
Scholar,
published
between
2006
2021.
Results
Cannabis
has
been
followed
by
substantial
reductions
arrests
prices.
It
also
increased
adults’
access
to
diverse
range
products,
including
edibles
extracts.
The
prevalence
among
young
adults
increased,
but
there
have
no
marked
increases
or
decreases
high
school
students
daily
near‐daily
use.
Legalization
associated
with
adult
hospital
attendances
psychiatric
distress
vomiting,
unintentional
ingestion
edible
children
hospitalizations
disorders
adults.
There
is
conflicting
evidence
whether
cannabis‐impaired
driving
suggestive
that
presentations
emergency
departments
psychoses
may
Conclusions
appears
reduced
variety
more
potent
at
lower
Since
2019,
recent
modestly
not
adolescents.
acute
adverse
effects
children.
Current Addiction Reports,
Journal Year:
2022,
Volume and Issue:
9(3), P. 217 - 234
Published: May 7, 2022
Abstract
Purpose
of
Review
The
purpose
this
review
was
to
describe
the
state-of-the-literature
on
research
specific
cannabis
vaping
among
youth
and
young
adults.
Recent
Findings
Out
1801
records
identified,
a
total
202
articles
met
eligibility
criteria
for
inclusion
in
review.
Most
literature
(46.0%
studies)
health
effects
vaping,
particularly
EVALI
(e-cigarette
associated
lung
injury).
Other
areas
identified
included
etiology
(24.3%)
epidemiology
(24.8%)
addition
regulation
(8.4%)
marketing
(5.5%)
same.
Summary
Cannabis
is
increasingly
common
adults
more
prevalent
settings
where
recreational
use
has
been
legalized.
documents
number
negative
people,
along
with
risk
factors
reasons
Drug and Alcohol Review,
Journal Year:
2023,
Volume and Issue:
42(5), P. 1114 - 1119
Published: March 18, 2023
Abstract
Introduction
An
increasing
number
of
countries
are
inthe
process
legalising
non‐medical
cannabis.
We
described
how
the
legal
market
has
changed
over
first
4
years
following
legalisation
in
Canada.
Methods
collected
longitudinal
data
on
operating
status
and
location
all
cannabis
stores
Canada
for
legalisation.
examined
per
capita
sales,
store
closures,
drive
time
between
each
neighbourhood
compared
measures
public
private
retail
systems.
Results
Four
after
legalisation,
there
were
3305
open
(10.6
100,000
individuals
aged
15+
years).
Canadians
spent
$11.85CAD
a
month
individual
years,
59%
neighbourhoods
within
5‐minute
store.
Over
sales
increased
year
by
an
average
122.3%
91.7%,
respectively,
with
larger
increases
versus
systems
(4.01
times
greater
2.46
sales).
The
annual
increase
during
3
was
6.0
15.5
greater,
than
fourth
7%
locations
permanently
closed.
Discussion
Conclusion
expanded
enormously
considerable
variation
access
jurisdictions.
rapid
expansion
implications
evaluation
health
impacts
Frontiers in Public Health,
Journal Year:
2024,
Volume and Issue:
11
Published: Jan. 5, 2024
Background
There
are
well-established
literatures
documenting
the
associations
between
mental
disorders
and
unhealthy
behaviors
such
as
poor
diet
quality,
sedentary
behavior,
cannabis
tobacco
use.
Few
studies
have
attempted
to
understand
respective
findings
in
light
of
each
other,
however.
Objective
The
purpose
this
review
was
assemble
comparable
data
for
behavior-disorder
association
assess
terms
their
overall
strength.
aimed
include
a
representative,
but
not
exhaustive,
range
that
would
allow
explorative
comparisons.
Methods
Eligible
were
identified
via
Pubmed
searches
citation
searching,
restricted
publications
no
older
than
2015
written
English.
To
obtain
data,
only
reported
odds
ratios
included,
risk
bias
related
study
samples,
behavioral
measurement
disparities,
control
variables
assessed
sensitivity
analyses.
Findings
disorder
compared
on
basis
different
measures
central
tendency.
Results
From
3,682
records,
294
included.
found
evidence
four
psychosis,
depression,
anxiety,
bipolar
disorder,
attention-deficit/hyperactivity
(ADHD),
post-traumatic
stress
(PTSD),
while
personality
investigated
relation
In
comparison,
generally
similar
strength,
use
exceptional
being
significantly
stronger
its
counterparts
across
behaviors.
Analyses
some
influence
from
disparities
lack
adequate
statistical
control,
robust
Conclusion
This
comparative
about
equally
strongly
associated
with
disorders.
Given
general
nature
these
associations,
we
should
probably
them
reflect
shared
etiology.
However,
be
regarded
tentative
until
confirmed
by
more
comprehensive
investigations.
Drug and Alcohol Review,
Journal Year:
2022,
Volume and Issue:
42(2), P. 277 - 298
Published: Sept. 27, 2022
Abstract
Issue
On
17
October
2018,
Canada
legalised
non‐medical
cannabis.
Critically,
the
cannabis
market
in
has
changed
considerably
since
legalisation.
In
this
scoping
review,
we
identified
available
evidence
on
changes
cannabis‐related
health
harms
following
legalisation
and
contextualised
findings
based
legal
indicators.
Approach
Electronic
searches
were
conducted
to
identify
studies
that
compared
pre‐
post‐legalisation.
We
each
study
by
mean
per
capita
stores
sales
during
period
means
2021—3
years
Implications
Conclusions
Some
measures
of
have
increased
but
date
captured
periods
relatively
low
maturity.
Longer‐term
monitoring
as
continues
expand
is
indicated.
Journal of Dual Diagnosis,
Journal Year:
2023,
Volume and Issue:
19(2-3), P. 71 - 96
Published: July 3, 2023
Objective:
Cannabis
use
is
increasingly
normalized;
psychosis
a
major
adverse
health
outcome.
We
reviewed
evidence
on
cannabis
use-related
risk
factors
for
outcomes
at
different
stages
toward
recommendations
reduction
by
individuals
involved
in
use.
Methods:
searched
primary
databases
pertinent
literature/data
2016
onward,
principally
relying
reviews
and
high-quality
studies
which
were
narratively
summarized
quality-graded;
developed
international
expert
consensus.
Results:
Genetic
risks,
mental
health/substance
problem
histories
elevate
the
risks
cannabis-related
psychosis.
Early
age-of-use-onset,
frequency-of-use,
product
composition
(i.e.,
THC
potency),
mode
other
substance
co-use
all
influence
risks;
protective
effects
of
CBD
are
uncertain.
Continuous
may
adversely
affect
psychosis-related
treatment
medication
effects.
Risk
factor
combinations
further
amplify
odds
outcomes.
Conclusions:
Reductions
identified
factors—short
abstinence—may
decrease
related
outcomes,
thereby
protect
users'
health.
Substance Abuse Treatment Prevention and Policy,
Journal Year:
2024,
Volume and Issue:
19(1)
Published: June 17, 2024
Abstract
Background
Canada
legalized
recreational
cannabis
in
2018,
and
one
of
the
primary
objectives
Cannabis
Act
was
to
protect
youth
by
reducing
their
access
providing
public
education.
has
highest
prevalence
use
worldwide,
particularly
among
young
adults
under
age
25.
is
linked
with
many
adverse
effects
for
including
psychosis,
anxiety,
depression,
respiratory
distress,
cannabinoid
hyperemesis
syndrome,
impaired
cognitive
performance.
Despite
high
evolution
policies
globally,
significant
knowledge
research
gaps
remain
regarding
adult
use.
The
aim
this
scoping
review
map
extent,
nature,
range
evidence
available
on
since
its
legalization,
order
strengthen
policies,
services,
treatments,
training,
education
strategies.
Methods
Using
a
framework
developed
Arksey
O’Malley,
along
PRISMA-ScR
guidelines,
we
conducted
rigorous
search
five
academic
databases:
MEDLINE,
Embase,
APA
PsycINFO,
CINAHL
Web
Science
Core
Collection.
We
included
empirical
studies
that
collected
data
after
legalization
(October
2018)
focused
or
<
30.
Two
reviewers
independently
screened
articles
two
stages
extracted
relevant
information
from
meeting
inclusion
criteria.
Results
Of
47
our
criteria,
92%
used
quantitative
methods,
6%
were
qualitative,
2%
mixed-methods
approach.
Over
two-thirds
(68%)
secondary
data.
These
categorized
into
six
focus
areas:
(1)
prevalence,
patterns,
trends,
(2)
cannabis-related
injuries
emergency
department
(ED)
visits,
(3)
rates
patterns
during
pandemic,
(4)
perceptions
use,
(5)
prevention
tools,
(6)
offenses.
Key
findings
reviewed
include
an
increase
18-24-year-olds
post-legalization,
mixed
results
18.
ED
visits
intentional
unintentional
have
increased
children
teens.
Perception
show
mix
concern
normalization
Though
limited,
are
promising
raising
awareness.
A
decline
offenses
noted
study.
highlights
several
gaps,
need
more
qualitative
data,
disaggregation
demographic
intervention
research,
comprehensive
physical
mental
health
impacts
adults.
Conclusion
Maintaining
approach
critical,
This
involves
implementing
strategies
minimize
harms,
enhancing
education,
minimizing
commercialization,
cannabis,
promoting
guidelines
lower-risk
harm
reduction
strategies,
increasing
training
healthcare
providers.
JAMA Network Open,
Journal Year:
2022,
Volume and Issue:
5(8), P. e2228088 - e2228088
Published: Aug. 23, 2022
Importance
The
cannabis
industry
has
sought
to
normalize
itself
and
expand
its
markets
in
the
21st
century.
One
strategy
used
by
companies
generate
positive
public
relations
is
corporate
social
responsibility
(CSR).
It
critical
understand
these
efforts
influence
politicians
given
risks
of
increased
use.
Objectives
To
analyze
CSR
behaviors,
determine
their
characteristics,
compare
practices
with
those
tobacco
industry.
Design,
Setting,
Participants
This
qualitative
study
activities
conducted
between
January
1,
2012,
December
31,
2021,
evaluated
9
10
largest
publicly
traded
US
Canada.
Data
were
collected
from
August
1
2021.
10th
company
was
excluded
because
it
engaged
cannabis-based
pharmaceutical
sales
but
not
CSR.
A
systematic
review
websites
Nexis
Uni
performed,
resulting
collection
153
news
articles,
press
releases,
Web
pages.
Charitable
philanthropic
actions
included.
Themes
identified
interpreted
using
modified
grounded
theory.
Main
Outcomes
Measures
spending.
Results
Nine
major
Canada
that
encouraged
consumption
targeted
marginalized
communities.
Companies
claimed
would
mitigate
harms
prohibition,
promote
diversity,
access
medical
cannabis,
support
charitable
causes.
They
developed
educational
programs,
sustainability
initiatives,
voluntary
marketing
codes
strategies
similar
recruit
interest
organizations
as
allies.
Conclusions
Relevance
These
findings
suggest
comparable
regulation,
suggesting
should
be
included
when
addressing
commercial
determinants
health.